Newman Regional Health’s Board of Trustees approved expenses for an upcoming renovation project to the hospital’s pharmacy.
The $250,000 project is required for Newman to comply with the regulations of United States Pharmacopeia 795, 797 and 800 which define drug compounding regulations. Chapters 797 and 800 will change current processes in the pharmacy related to injectable medications for both inpatient and outpatient services if Newman does not comply.
CEO Bob Wright says the new mandates will aid both hospital staff and patients alike.
Essentially the new renovation will aid Newman Regional Health in two areas, sterile and non-sterile compounding. Non-sterile compounding refers to creating medication in a clean environment but does not require the environment to be completely clear from all microorganisms normally used for oral or topical medications. Sterile compounding refers to creating medications in an environment free from viruses, bacteria and other potentially infectious microorganisms normally used for medications administered by injection or intravenously.
Ashley Edwards, Newman’s director of Pharmacy says in a statement updating the facility will allow Newman to create patient-tailored medications and help battle drug shortages and costs.
Wright adds the renovation will serve as a cost-saving measure, as without it they would be forced to purchase compounded drugs from outside sources.
The board unanimously approved the $250,000 project. No specific date has been given for the project’s completion. The new USP chapters will go into effect December 1, 2019.
In other business board members discussed the hospital’s do not resuscitate policy, revisited the active shooter policy which was discussed at last month’s meeting and received updates on the hospital’s financial status.
